SHP Announces the Official Launch of Indonesia MERSI Vaccine Cleanroom Project

SHP is excited to announce that the construction works for the Indonesia MERSI Vaccine Cleanroom Project have officially begun. This marks a significant milestone in our global expansion of high-end biomedical purification engineering. Drawing on our extensive technical expertise in the cleanroom sector and our well-established experience in cross-border project delivery, SHP is dedicated to providing premium, high-precision, GMP-compliant integrated cleanroom solutions for Indonesia’s critical vaccine manufacturing infrastructure.

A Flagship Project for Indonesia’s Biomedical Sector

As a flagship biomedical facility project in Indonesia, the MERSI vaccine production cleanroom is held to the highest standards of cleanliness, environmental stability, and risk control. The facility has stringent specifications on air cleanliness, temperature and humidity control, differential pressure stability, sterile dust-free isolation, and full life-cycle cross-contamination management. Vaccine production demands the highest quality controlled environments, where the cleanliness of the space directly impacts the safety, consistency, and qualification rates of vaccine products.

In compliance with Indonesia’s pharmaceutical regulations and international GMP standards for vaccine production, SHP’s expert technical team has completed all essential pre-construction activities ahead of schedule. This includes aligning on-site plans, verifying construction drawings, certifying the quality of incoming materials, and scheduling the overall project progress.

Collaboration and Coordination for Success

On-site, multidisciplinary teams of Chinese and Indonesian engineers have worked closely together through technical seminars and joint on-site inspections. The teams meticulously reviewed core cleanroom materials, including thermal insulation purification media and stainless steel duct components, to clarify construction specifications, quality acceptance standards, construction milestones, and on-site safety protocols.

All materials have undergone rigorous multi-layer quality checks and meet the dust-free, corrosion-resistant, and low-outgassing environmental standards essential for vaccine-grade cleanrooms. This ensures a solid foundation for the subsequent standardized construction processes.

Commitment to World-Class Standards

Throughout the project’s implementation, SHP is committed to adhering to world-class cleanroom construction standards and pharmaceutical GMP design and construction specifications. Our team will manage all aspects of the project, including cross-border coordination, technical handovers, construction supervision, and post-completion system commissioning.

We are focused on every construction detail, from duct installations and purification system layouts to enclosure structure construction and HVAC air system integration. This attention to detail ensures the creation of a fully sealed, highly stable, sterile clean production environment, perfectly adapted to Indonesia’s climate and the full vaccine production workflow.

Strengthening SHP’s Market Competitiveness in Southeast Asia

The official launch of the Indonesia MERSI Vaccine Cleanroom Project further strengthens SHP’s competitive edge in the biomedical clean engineering market in Southeast Asia. Looking ahead, SHP will continue to deepen global cleanroom engineering cooperation. With our professional purification technology, standardized project management, and full-lifecycle after-sales services, we are dedicated to supporting pharmaceutical, vaccine, and high-precision manufacturing industries worldwide. We are committed to helping businesses build compliant, reliable, and efficient dust-free cleanrooms, further driving the sustainable development of the global biomedical cleanroom industry.